Implant Sciences Signs Testing Agreements for Quantum Sniffer QS-B220
- Explosives and Narcotics Trace Detector to Be Deployed at Airports and Air Cargo Facilities
"We are pleased with the enthusiastic response the QS-B220 is receiving from the user community. Containing no radioactive materials, Implant Sciences' products screen passengers and cargo without health or environmental risks," stated Implant Sciences CEO, Glenn D. Bolduc.
Global Bio-Sensors Market for non-clinical Applications 2016-2020
Todd Silvestri, Vice President of Product Development added, "The QS-B220 has been designed to meet or exceed all TSA requirements. With automatic calibration, high throughput, and low maintenance needs, the system is ideally suited for security screening applications."
Source : Implant Sciences Corp.
Feb 21 - 22, 2017 - London, United Kingdom